Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyDrug Reaction DataReferences

View all Images (22)

Merkel cell carcinoma
Other Resources UpToDate PubMed

Merkel cell carcinoma

Contributors: Ryan Fan BA, Jeffrey M. Cohen MD, Belinda Tan MD, PhD, Susan Burgin MD
Other Resources UpToDate PubMed

Synopsis

Merkel cell carcinoma (MCC), also known as cutaneous neuroendocrine carcinoma, is a rare skin malignancy that demonstrates both neuroendocrine and epithelial differentiation. In spite of its name, the cell of origin of MCC has not been proven to be the Merkel cell and is still under debate.

MCC favors older adults, with a median age of 75-80 years at the time of diagnosis. It is more common among individuals of Northern European descent than those of African, Asian, or Hispanic descent. MCC is also more common in immunocompromised individuals. Two important etiologic factors for MCC are the Merkel cell polyomavirus (MCPyV) and ultraviolet (UV) exposure. Patients with MCC who are polyomavirus negative have more aggressive tumors.

MCC typically presents as an asymptomatic, firm, nontender, solitary, rapidly growing nodule. It occurs most frequently on the head and neck but can also be seen elsewhere on the body.

A high index of suspicion is needed for diagnosis. In one study, the most frequent prebiopsy diagnosis rendered was of a benign lesion, such as an acneiform lesion or cyst.

Despite aggressive treatment, recurrence rates are high, metastases are common, and 5-year relative survival is approximately 60% in the United States based on data from a national database from 2005-2014. The recurrence rate of MCC has been estimated to be approximately 40%, and the majority (90%) have been observed within the first 3 years. Factors associated with an increased risk of recurrence include higher pathologic stage, immunosuppression, male sex, older age, and a known primary lesion in patients with clinically detectable nodal disease. Survival rates were higher in women (68%), lower in non-Hispanic Black individuals (54%), and decreased with later stage, number of lymph nodes involved, and older age at diagnosis, as well as with the involvement of certain locations such as the trunk.

MCC, as with other neuroendocrine tumors, has been associated with rare paraneoplastic neurologic syndromes, and patients may present with neurologic symptoms such as ataxia, weakness, and confusion.

Codes

ICD10CM:
C4A.9 – Merkel cell carcinoma, unspecified

SNOMEDCT:
253001006 – Merkel cell carcinoma

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

Drug Reaction Data

Below is a list of drugs with literature evidence indicating an adverse association with this diagnosis. The list is continually updated through ongoing research and new medication approvals. Click on Citations to sort by number of citations or click on Medication to sort the medications alphabetically.

Subscription Required

References

Subscription Required

Last Reviewed:06/26/2022
Last Updated:06/29/2022
Copyright © 2022 VisualDx®. All rights reserved.
Merkel cell carcinoma
A medical illustration showing key findings of Merkel cell carcinoma : Smooth papule, Tumor, Sun-exposed distribution, Firm nodule
Clinical image of Merkel cell carcinoma - imageId=227416. Click to open in gallery.  caption: 'A close-up of an eroded pink nodule.'
A close-up of an eroded pink nodule.
Copyright © 2022 VisualDx®. All rights reserved.